
TY  - JOUR
TI  - Meetings
JO  - Journal of the American Oil Chemists' Society
JA  - J Am Oil Chem Soc
VL  - 62
IS  - 4
SN  - 0003-021X
UR  - https://doi.org/10.1007/BF03028722
DO  - doi:10.1007/BF03028722
SP  - 574
EP  - 663
PY  - 1985
ER  - 

TY  - JOUR
TI  - ICIEM Abstracts
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 36
IS  - S2
SN  - 0141-8955
UR  - https://doi.org/10.1007/s10545-013-9633-z
DO  - doi:10.1007/s10545-013-9633-z
SP  - 91
EP  - 342
PY  - 2013
ER  - 

TY  - JOUR
TI  - Seventh Congress of the International BioIron Society (IBIS) Biennial World Meeting (BioIron 2017) May 7 – 11, 2017
JO  - American Journal of Hematology
JA  - Am J Hematol
VL  - 92
IS  - 8
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.24812
DO  - doi:10.1002/ajh.24812
SP  - E178
EP  - E506
PY  - 2017
ER  - 

TY  - JOUR
TI  - FOURTH ANNUAL MEETING AMERICAN SOCIETY FOR LASER MEDICINE AND SURGERY SALT LAKE CITY, UTAH JUNE 4–6, 1984
JO  - Lasers in Surgery and Medicine
JA  - Lasers Surg. Med.
VL  - 3
IS  - 4
SN  - 0196-8092
UR  - https://doi.org/10.1002/lsm.1900030407
DO  - doi:10.1002/lsm.1900030407
SP  - 305
EP  - 369
PY  - 1984
ER  - 

TY  - JOUR
C7  - e13385
TI  - Poster Session B
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 227
IS  - S719
SN  - 1748-1708
UR  - https://doi.org/10.1111/apha.13385
DO  - doi:10.1111/apha.13385
SP  - e13385
PY  - 2019
ER  - 

TY  - JOUR
TI  - FREE COMMUNICATIONS  POSTER COMMUNICATIONS
JO  - Nephrology
VL  - 10
IS  - s1
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2005.00419.x
DO  - doi:10.1111/j.1440-1797.2005.00419.x
SP  - A1
EP  - A116
PY  - 2005
ER  - 

TY  - JOUR
AU  - Olmos, Ana
AU  - Giner, Rosa M.
AU  - Máñez, Salvador
TI  - Drugs modulating the biological effects of peroxynitrite and related nitrogen species
JO  - Medicinal Research Reviews
JA  - Med. Res. Rev.
VL  - 27
IS  - 1
SN  - 0198-6325
UR  - https://doi.org/10.1002/med.20065
DO  - doi:10.1002/med.20065
SP  - 1
EP  - 64
KW  - peroxynitrite
KW  - reactive nitrogen species
KW  - tyrosine nitration
KW  - antioxidants
KW  - NOS
KW  - PARP inhibitors
PY  - 2007
AB  - Abstract The term ?reactive nitrogen species? includes nitrogen monoxide, commonly called nitric oxide, and some other remarkable chemical entities (peroxynitrite, nitrosoperoxycarbonate, etc.) formed mostly from nitrogen monoxide itself in biological environments. Regardless of the specific mechanisms implicated in their effects, however, it is clear that an integrated pharmacological approach to peroxynitrite and related species is only just beginning to take shape. The array of affected chemical and pathological processes is extremely broad. One of the most conspicuous mechanisms observed thus far has been the scavenging of the peroxynitrite anion by molecules endowed with antioxidant activity. This discovery has in turn lent great significance to several naturally occurring and synthetic antioxidants, which usually protect not only against oxidative reactions, but also from nitrating ones, both in vitro and in vivo. This has proven to be beneficial in different tissues, especially within the central nervous system. Taking these results and those of other biochemical investigations into account, many research lines are currently in progress to establish the true potential of reactive nitrogen species deactivators in the therapy of neurological diseases, ischemia-reperfusion damage, renal failure, and lung injury, among others. ? 2006 Wiley Periodicals, Inc. Med Res Rev, 27, No. 1, 1?64, 2007
ER  - 

TY  - JOUR
TI  - POSTER SESSIONS
JO  - Allergy
VL  - 62
IS  - s83
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2007.01407.x
DO  - doi:10.1111/j.1398-9995.2007.01407.x
SP  - 167
EP  - 551
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Cachexia, Sarcopenia and Muscle
JA  - Journal of Cachexia, Sarcopenia and Muscle
VL  - 10
IS  - 6
SN  - 2190-5991
UR  - https://doi.org/10.1002/jcsm.12513
DO  - doi:10.1002/jcsm.12513
SP  - 1378
EP  - 1435
PY  - 2019
ER  - 

TY  - JOUR
AU  - Ghatak, Swagata
AU  - Banerjee, Aditi
AU  - Sikdar, Sujit Kumar
TI  - Ischaemic concentrations of lactate increase TREK1 channel activity by interacting with a single histidine residue in the carboxy terminal domain
JO  - The Journal of Physiology
JA  - J Physiol
VL  - 594
IS  - 1
SN  - 0022-3751
UR  - https://doi.org/10.1113/JP270706
DO  - doi:10.1113/JP270706
SP  - 59
EP  - 81
PY  - 2016
AB  - Key points The physiological metabolite, lactate and the two-pore domain leak potassium channel, TREK1 are known neuroprotectants against cerebral ischaemia. However, it is not known whether lactate interacts with TREK1 channel to provide neuroprotection. In this study we show that lactate increases TREK1 channel activity and hyperpolarizes CA1 stratum radiatum astrocytes in hippocampal slices. Lactate increases open probability and decreases longer close time of the human (h)TREK1 channel in a concentration dependent manner. Lactate interacts with histidine 328 (H328) in the carboxy terminal domain of hTREK1 channel to decrease its dwell time in the longer closed state. This interaction was dependent on the charge on H328. Lactate-insensitive mutant H328A hTREK1 showed pH sensitivity similar to wild-type hTREK1, indicating that the effect of lactate on hTREK1 is independent of pH change. Abstract A rise in lactate concentration and the leak potassium channel TREK1 have been independently associated with cerebral ischaemia. Recent literature suggests lactate to be neuroprotective and TREK1 knockout mice show an increased sensitivity to brain and spinal cord ischaemia; however, the connecting link between the two is missing. Therefore we hypothesized that lactate might interact with TREK1 channels. In the present study, we show that lactate at ischaemic concentrations (15?30 mm) at pH 7.4 increases TREK1 current in CA1 stratum radiatum astrocytes and causes membrane hyperpolarization. We confirm the intracellular action of lactate on TREK1 in hippocampal slices using monocarboxylate transporter blockers and at single channel level in cell-free inside-out membrane patches. The intracellular effect of lactate on TREK1 is specific since other monocarboxylates such as pyruvate and acetate at pH 7.4 failed to increase TREK1 current. Deletion and point mutation experiments suggest that lactate decreases the longer close dwell time incrementally with increase in lactate concentration by interacting with the histidine residue at position 328 (H328) in the carboxy terminal domain of the TREK1 channel. The interaction of lactate with H328 is dependent on the charge on the histidine residue since isosteric mutation of H328 to glutamine did not show an increase in TREK1 channel activity with lactate. This is the first demonstration of a direct effect of lactate on ion channel activity. The action of lactate on the TREK1 channel signifies a separate neuroprotective mechanism in ischaemia since it was found to be independent of the effect of acidic pH on channel activity.
ER  - 

TI  - Haemosiderin to Hormone-Sensitive Lipase: Iduronate-2-Sulphatase to Interleukin-1 Receptor Antagonist
SN  - 9783527300938
UR  - https://doi.org/10.1002/9783527619764.ch8
DO  - doi:10.1002/9783527619764.ch8
KW  - iron storage protein
KW  - lysosomes
KW  - ferrioxyhydrite
KW  - mineralisation
KW  - haemochromatosis
PY  - 2016
ER  - 

TY  - JOUR
TI  - The 2nd Congress of Asian Society for Pediatric Research
JO  - Pediatrics International
VL  - 49
IS  - 5
SN  - 9783527300938
UR  - https://doi.org/10.1111/j.1442-200X.2007.02473.x
DO  - doi:10.1111/j.1442-200X.2007.02473.x
SP  - 691
EP  - 792
PY  - 2007
ER  - 

TY  - JOUR
TI  - Oral Session
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 23
IS  - S2
SN  - 9783527300938
UR  - https://doi.org/10.1111/ene.13091
DO  - doi:10.1111/ene.13091
SP  - 21
EP  - 110
PY  - 2016
ER  - 

TY  - JOUR
AU  - Malchesky, Paul S.
TI  - Artificial Organs 2008: A Year in Review
JO  - Artificial Organs
VL  - 33
IS  - 3
SN  - 9783527300938
UR  - https://doi.org/10.1111/j.1525-1594.2009.00718.x
DO  - doi:10.1111/j.1525-1594.2009.00718.x
SP  - 273
EP  - 295
KW  - Anticoagulation
KW  - Apheresis
KW  - Artificial blood
KW  - Biocompatibility
KW  - Blood access
KW  - Blood pumps
KW  - Cardiac
KW  - Cardiopulmonary
KW  - Dermal
KW  - Dental
KW  - Dialysis
KW  - Digestive
KW  - Liver
KW  - Membrane oxygenation
KW  - Neuromuscular
KW  - Orthopedic
KW  - Oxygen carriers
KW  - Pancreatic
KW  - Renal
KW  - Stomach
KW  - Tissue engineering
KW  - Urologic
KW  - Valves
KW  - Vascular
KW  - Vision
PY  - 2009
ER  - 

TY  - JOUR
TI  - Hemodialysis Abstracts from the Annual Dialysis Conference 29th Annual Conference on Peritoneal Dialysis, 15th International Symposium on Hemodialysis, and 20th Annual Symposium on Pediatric Dialysis Houston, Texas March 8–10, 2009
JO  - Hemodialysis International
VL  - 13
IS  - 1
SN  - 9783527300938
UR  - https://doi.org/10.1111/j.1542-4758.2009.00325.x
DO  - doi:10.1111/j.1542-4758.2009.00325.x
SP  - 92
EP  - 137
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Fundamental & Clinical Pharmacology
VL  - 21
IS  - s1
SN  - 9783527300938
UR  - https://doi.org/10.1111/j.1472-8206.2007.00481.x
DO  - doi:10.1111/j.1472-8206.2007.00481.x
SP  - 1
EP  - 99
PY  - 2007
ER  - 

TY  - JOUR
TI  - Current Awareness in Drug Testing and Analysis
JO  - Drug Testing and Analysis
JA  - Drug Test Analysis
VL  - 1
IS  - 6
SN  - 9783527300938
UR  - https://doi.org/10.1002/dta.3
DO  - doi:10.1002/dta.3
SP  - 292
EP  - 309
PY  - 2009
AB  - Abstract In order to keep subscribers up-to-date with the latest developments in their field, John Wiley  2 Sports doping - General; 3 Steroids; 4 Peptides; 5 Diuretics; 6 CNS agents; 7 Equine; 8 Recreational drugs - General; 9 Stimulants; 10 Hallucinogens; 11 Narcotics; 12 Forensics; 13 Alcohol; 14 Tobacco; 15 Homeland security; 16 Workplace; 17 Product authenticity; 18 Techniques. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.
ER  - 

TY  - JOUR
TI  - Self reactivity and its regulation
JO  - Journal of Cellular Biochemistry
JA  - J. Cell. Biochem.
VL  - 47
IS  - S15A
SN  - 9783527300938
UR  - https://doi.org/10.1002/jcb.240470504
DO  - doi:10.1002/jcb.240470504
SP  - 215
EP  - 323
PY  - 1991
ER  - 

TY  - JOUR
TI  - Invited Lectures
JO  - The FEBS Journal
VL  - 275
IS  - s1
SN  - 9783527300938
UR  - https://doi.org/10.1111/j.1742-4658.2008.06445.x
DO  - doi:10.1111/j.1742-4658.2008.06445.x
SP  - 4
EP  - 64
PY  - 2008
ER  - 

TY  - JOUR
TI  - Poster presentation: Thursday 30 August 2007
JO  - Basic & Clinical Pharmacology & Toxicology
VL  - 101
IS  - s1
SN  - 9783527300938
UR  - https://doi.org/10.1111/j.1742-7843.2007.00104.x
DO  - doi:10.1111/j.1742-7843.2007.00104.x
SP  - 103
EP  - 157
PY  - 2007
ER  - 
